Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 3 1Phase 2 1Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 1Carcinoma, Squamous Cell 1

Interventions

3-ingenyl angelate 11Photochemotherapy 7Aminolevulinic Acid 7Imiquimod 6methyl 5-aminolevulinate 5Fluorouracil 5Gels 4Diclofenac 4Cryotherapy 3BF-200 ALA 3tirbanibulin 2Therapeutics 2Solutions 2green tea extract polyphenone E 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1Ointments 1LEO 43204 1Drugs, Generic 1Deoxyribonuclease (Pyrimidine Dimer) 1Cryosurgery 1Cosmetics 15-fluorouracil, salicylic acid drug combination 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Keratosis, Actinic × LEO 43204 × Clear all
NCT03115476 2025-03-11

A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp

LEO Pharma

Phase 3 Terminated
563 enrolled 15 charts
Dermatologic

Carcinoma, Squamous Cell, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡